Anterior|Siguiente

Effect of Anmeidan in Ameliorating Neuronal Synaptic Structural and Functional Impairment in Aged Sleep Deprivation Model via EphA4/ephrinA3 Signaling Pathway

  • role： First author第一作者
  • Affiliation：

    Engineering Center of the Ministry of Education， Hubei University of Chinese Medicine， Wuhan 430065， China

  • Email：414137538@qq.com
  • Introduction：张军路，在读硕士，从事中医延缓衰老理论及应用研究，E-mail：414137538@qq.com
ZHANG Junlu1,  
  • role： Corresponding author通信作者
  • Affiliation：

    Engineering Center of the Ministry of Education， Hubei University of Chinese Medicine， Wuhan 430065， China

    Hubei Shizhen Laboratory， Wuhan 430065， China

  • Email：397525306@qq.com
  • Introduction：谢光璟，博士，副教授，硕士生导师，从事中医药防治老年病研究，E-mail：397525306@qq.com
XIE Guangjing12*,  
  • Affiliation：

    Engineering Center of the Ministry of Education， Hubei University of Chinese Medicine， Wuhan 430065， China

    Hubei Shizhen Laboratory， Wuhan 430065， China

WANG Ping12

resumen

ObjectiveTo investigate the effects of Anmeidan （AMD） on protein expression of the ephrin type-A receptor 4 （EphA4）/ephrinA3 signaling pathway and synaptic structural function in an aged sleep deprivation model.MethodsSeventy-two 18-month-old aged mice were randomly divided into a blank group， a model group， AMD high-， medium-， and low-dose groups （26.26， 13.13， 6.565 g·kg-1·d-1， respectively）， and a melatonin group （1.3 mg·kg-1·d-1）， with 12 mice in each group. Cognitive function was assessed using the novel object recognition test. Hematoxylin-eosin （HE） staining was used to observe cell number and morphology in hippocampal tissues， and Nissl staining was performed to examine cellular structure and quantify Nissl bodies. Transmission electron microscopy was used to observe synaptic ultrastructure， with emphasis on changes in synaptic morphology and structure. Western blot was employed to detect the expression levels of EphA4， ephrinA3， brain-derived neurotrophic factor （BDNF）， glutamate aspartate transporter （GLAST）， glutamate transporter-1 （GLT-1）， growth-associated protein 43 （GAP43）， postsynaptic density protein 95 （PSD95）， and synaptophysin （SYN） in hippocampal tissues. Immunofluorescence double labeling was performed to co-stain EphA4 and ephrinA3 with glial fibrillary acidic protein （GFAP） and neuronal nuclei antigen （NeuN）， respectively， to observe the colocalization of target proteins with neurons and astrocytes.ResultsCompared with the blank group， the model group exhibited increased exploration time of familiar objects （P<0.01）， while exploration time of novel objects and the recognition index were decreased （P<0.01）. The number of neurons in the CA1， CA3， and dentate gyrus （DG） regions of the hippocampus was reduced， Nissl bodies were decreased， and synaptic structures were damaged. Protein expression levels of BDNF， GLAST， GLT-1， GAP43， PSD95， and SYN in hippocampal tissues were decreased， whereas the expression levels of EphA4， ephrinA3， and GFAP were increased. Compared with the model group， the AMD low-， medium-， and high-dose groups and the melatonin group showed increased exploration time of novel objects and higher novel object recognition indices （P<0.01）， along with significantly reduced exploration time of familiar objects （P<0.01）. Neuronal damage in the CA1 and DG regions was ameliorated， the number of Nissl bodies in the CA1 region was increased， and organelle and synaptic structural damage was alleviated. Protein expression levels of BDNF， GLAST， GLT-1， GAP43， PSD95， and SYN were increased， and protein expression levels of EphA4， ephrinA3， and GFAP were decreased （P<0.05，P<0.01）.ConclusionAMD can regulate protein expression of the EphA4/ephrinA3 signaling pathway in an aged sleep deprivation model， enhance synaptic protein expression， and improve neuronal synaptic damage.

palabra clave

Anmeidan （AMD）;sleep deprivation;ephrin type-A receptor 4 （EphA4）/ephrinA3 signaling pathway;synapse;astrocyte

References

  1. 1.
    RIEMANN D，NISSEN C，PALAGINI L，et al.The neurobiology，investigation，and treatment of chronic insomnia［J］.Lancet Neurol，2015，14（5）：547-558.
  2. 2.
    BUYSSE D J.Insomnia［J］.JAMA，2013，309（7）：706-716.
  3. 3.
    CUNNINGTON D，JUNGE M F，FERNANDO A T.Insomnia：Prevalence，consequences and effective treatment［J］.Med J Aust，2013，199（8）：S36-S40.
  4. 4.
    XU L J，WANG H N，ZHOU H，et al.EphA4/ephrinA3 reverse signaling induced Müller cell gliosis and production of pro-inflammatory cytokines in experimental glaucoma［J］.Brain Res，2023，1801：148204.
  5. 5.
    CHEN J C，ESPELAND M A，BRUNNER R L，et al.Sleep duration，cognitive decline，and dementia risk in older women［J］.Alzheimers Dement，2016，12（1）：21-33.
  6. 6.
    YANG J，TAN Y X，WANG P，et al.Effects of Anmei Dan on serum BDNF，GFAP and irisin in patients with chronic insomnia［J］.Chin J Exp Tradit Med Form，2023，29（16）：170-177.
  7. 7.
    XIE G J，XU B，XIA J，et al.Protective effects of Anmei Dan on hippocampal CA1 region cell structure and neuronal damage in sleep-deprived rats［J］.Chin J Exp Tradit Med Form，2022，28（7）：26-32.
  8. 8.
    XIE G J，XU Z X，ZHANG J L，et al.Protective effect and mechanism of Anmei Dan on neuronal damage in sleep-deprived rat model based on hippocampal neuroinflammation［J］.Chin J Exp Tradit Med Form，2025，31（10）：65-71.
  9. 9.
    WEN C.Study on the material basis and P2X7R/p38MAPK inflammatory mechanism of Shenghui decoction in improving learning and memory in sleep-deprived model mice［D］.Wuhan：Hubei University of Chinese Medicine，2023.
  10. 10.
    CHEN Q，SUN J N，LIN Z B，et al.Methodology of pharmacological research on traditional Chinese medicine［M］.2nd ed.Beijing：People's Medical Publishing House，2006.
  11. 11.
    XIE G J，XU B，HUANG P P，et al.Regulation of Anmei Dan on circadian rhythm of spontaneous activity and its effect on clock proteins in sleep-deprived rats［J］.Chin J Exp Tradit Med Form，2022，28（7）：33-39.
  12. 12.
    ZHANG J L，SUN K，WU Y X，et al.Exploration of the mechanism of Anmei Dan in improving cognitive impairment induced by senile sleep deprivation model based on Cyt C-regulated apoptotic pathway［J］.Chin J Exp Tradit Med Form，2024，30（19）：1-9.
  13. 13.
    GAO Y，XU B，XIA J，et al.Chemical composition analysis of anmei dan and its mechanism in improving circadian rhythm of insomniac rats by regulating ERK1/2/MNK/eIF4E signaling pathway［J］.Chin J Exp Tradit Med Form，2025，31（10）：44-53.
  14. 14.
    FENG Y，SHI R，HU J，et al.Effects of neural-derived estradiol on actin polymerization and synaptic plasticity-related proteins in prefrontal and hippocampal cells of mice［J］.Steroids，2022，177：108935.
  15. 15.
    ENDO F，KASAI A，SOTO J S，et al.Molecular basis of astrocyte diversity and morphology across the CNS in health and disease［J］.Science，2022，378（6619）：eadc9020.
  16. 16.
    ZHAO G，LIU X L，QIAO D C.Lateral inhibitory effect of striatal medium spiny neurons and regulation of basal ganglia motor function［J］.Prog Physiol Sci，2019，50（1）：58-62.
  17. 17.
    PAREKH P K，JOHNSON S B，LISTON C.Synaptic Mechanisms Regulating Mood State Transitions in Depression［J］.Annu Rev Neurosci，2022，45：581-601.
  18. 18.
    MAYNARD S A，RANFT J，TRILLER A.Quantifying postsynaptic receptor dynamics：Insights into synaptic function［J］.Nat Rev Neurosci，2023，24（1）：4-22.
  19. 19.
    XIE G J，XU B，XIA J，et al.Study on the protective effect of anmei dan on hippocampal neuronal damage and synaptic microenvironment in sleep-deprived rats based on NRG1/ErbB4 signaling pathway［J］.China J Chin Mater Med，2024，49（18）：4957-4966.
  20. 20.
    BIAN L H，YAO Z W，ZHAOC B，et al.Nardosinone alleviates Parkinson's disease symptoms in mice by regulating dopamine D2 receptor［J］.Evid Based Complement Alternat Med，2021，doi：.
  21. 21.
    AMANOLLAHI M，JAMEIE M，HEIDARI A，et al.The dialogue between neuroinflammation and adult neurogenesis：Mechanisms involved and alterations in neurological diseases［J］.Mol Neurobiol，2023，60（2）：923-959.
  22. 22.
    RUGGIERO R N，ROSSIGNOLI M T，MARQUES D B，et al.Neuromodulation of hippocampal-prefrontal cortical synaptic plasticity and functional connectivity：Implications for neuropsychiatric disorders［J］.Front Cell Neurosci，2021，15：732360.
  23. 23.
    TANASIC S，MATTUSCH C，WAGNER E M，et al.Desipramine targets astrocytes to attenuate synaptic plasticity via modulation of the ephrinA3/EphA4 signalling［J］.Neuropharmacology，2016，105：154-163.
  24. 24.
    LI Y，SU P，CHEN Y，et al.The Eph receptor A4 plays a role in demyelination and depression-related behavior［J］.J Clin Invest，2022，132（8）：e152187.
  25. 25.
    SMITH L M，KOSTYLEV M A，LEE S，et al.Systematic and standardized comparison of reported amyloid-β receptors for sufficiency，affinity，and Alzheimer's disease relevance［J］.J Biol Chem，2019，294（15）：6042-6053.
  26. 26.
    MURAI K K，NGUYEN L N，IRIE F，et al.Control of hippocampal dendritic spine morphology through ephrin-A3/EphA4 signaling［J］.Nat Neurosci，2003，6（2）：153-160.
  27. 27.
    BOURGIN C，MURAI K K，RICHTER M，et al.The EphA4 receptor regulates dendritic spine remodeling by affecting beta1-integrin signaling pathways［J］.J Cell Biol，2007，178（7）：1295-1307.
  28. 28.
    GROC L，CHOQUET D.Linking glutamate receptor movements and synapse function［J］.Science，2020，368（6496）：4631.
  29. 29.
    PIETRANCOSTA N，DJIBO M，DAUMAS S，et al.Molecular，structural，functional，and pharmacological sites for vesicular glutamate transporter regulation［J］.Mol Neurobiol，2020，57（7）：3118-3142.
  30. 30.
    LIU J H，ZHANG M，WANG Q，et al.Distinct roles of astroglia and neurons in synaptic plasticity and memory［J］.Mol Psychiatry，2022，27（2）：873-885.
  31. 31.
    BRANDEBURA A N，PAUMIER A，ONUR T S，et al.Astrocyte contribution to dysfunction，risk and progression in neurodegenerative disorders［J］.Nat Rev Neurosci，2023，24（1）：23-39.
  32. 32.
    UPADHYA R，ZINGG W，SHETTY S，et al.Astrocyte-derived extracellular vesicles：Neuroreparative properties and role in the pathogenesis of neurodegenerative disorders［J］.J Control Release，2020，323：225-239.
  33. 33.
    TRUDLER D，SANZ-BLASCO S，EISELE Y S，et al.α-Synuclein oligomers induce glutamate release from astrocytes and excessive extrasynaptic NMDAR activity in neurons，thus contributing to synapse loss［J］.J Neurosci，2021，41（10）：2264-2273.
  34. 34.
    GAO H，ZHANG Y，LUO D，et al.Activation of the hippocampal DRD2 alleviates neuroinflammation，synaptic plasticity damage and cognitive impairment after sleep deprivation［J］.Mol Neurobiol，2023，60（12）：7208-7221.
  35. 35.
    KOJIMA M，MIZUI T.BDNF propeptide：A novel modulator of synaptic plasticity［J］.Vitam Horm，2017，104：19-28.
  36. 36.
    KWON S E，CHAPMAN E R.Synaptophysin regulates the kinetics of synaptic vesicle endocytosis in central neurons［J］.Neuron，2011，70（5）：847-854.
  37. 37.
    FU R，XU G Z，ZHU H J，et al.（2021）.Research progress on the effect of transcranial magnetic stimulation on learning and memory and brain neural synaptic plasticity［J］.J Biomed Eng，38（4）：783-789.
  38. 38.
    MARDONES M D，JORQUERA P V，HERRERA-SOTO A，et al.PSD95 regulates morphological development of adult-born granule neurons in the mouse hippocampus［J］.J Chem Neuroanat，2019，98：117-123.

Leer el texto completo

The above content is generated by Large Model Translation. The translated content is for reference only. We do not assume any commercial or legal responsibilty for any consequences arising from the use of our website